Table of Contents

Summary of Sites by Race and Sex

Section 2

Summary of Sites by Stage
Table 2-1: Indiana Cases 1996 - 2000

Site Number* of Cases SEER** Summary Stage at Diagnosis
In Situ Local Regional Distant Unstaged
All Sites 139,4189,272 58,16431,381 28,09712,504
Oral Cavity and Pharynx 3,11976 1,2521,423 185183
Lip 31616 26812 218
Tongue 70117 278329 3641
Salivary Gland 3302 175116 1720
Floor of Mouth 25415 112105 616
Gum and Other Mouth 52014 235206 3332
Nasopharynx 1410 1493 2311
Tonsil 4027 75283 2413
Oropharynx 1071 2665 87
Hypopharynx 2442 51155 2511
Other Oral Cavity and Pharynx 1042 1859 1114
Digestive System 26,7281,401 7,40010,110 5,6222,195
Esophagus 1,43230 353471 376202
Stomach 1,67014 346606 488216
Small Intestine 4924 129197 12042
Colon and Rectum 17,8911,281 5,6057,159 2,931915
Colon excluding Rectum 13,004894 3,9565,372 2,208574
Cecum 2,978138 8491,368 53093
Appendix 1292 4040 3512
Ascending Colon 2,203116 6541,024 33376
Hepatic Flexure 74722 224357 10638
Transverse Colon 1,11450 341506 17047
Splenic Flexure 43216 102232 766
Descending Colon 67656 215283 9725
Sigmoid Colon 3,928405 1,3811,398 632112
Large Intestine, NOS 79789 150164 229165
Rectum and Rectosigmoid Junction 4,887387 1,6491,787 723341
Rectosigmoid Junction 1,43468 402625 27663
Rectum 3,453319 1,2471,162 447278
Anus, Anal Canal and Anorectum 43644 207108 3839
Liver and Intrahepatic Bile Duct 9550 307170 242236
Liver 7800 265123 215177
Intrahepatic Bile Duct 1750 4247 2759
Gallbladder 33013 87117 9716
Other Biliary 3727 84155 5472
Pancreas 2,8127 2341,068 1,120383
Retroperitoneum 1170 3934 2321
Peritoneum, Omentum and Mesentery 1560 620 10228
Other Digestive Organs 651 35 3125
Respiratory System 24,588137 5,7626,356 10,0322,301
Nose, Nasal Cavity and Middle Ear 1884 4185 3325
Larynx 1,59297 923451 5962
Lung and Bronchus 22,52236 4,7205,735 9,8912,140
Pleura 2500 6675 4366
Trachea, Mediastinum and Other Respiratory Organs 360 1210 68
Bones and Joints 2670 11587 3233
Soft Tissue including Heart 8180 468137 12291
Skin excluding Basal and Squamous 5,0661,013 3,240308 198307
Melanoma of the Skin 4,7021,008 2,992294 151257
Other Non-Epithelial Skin 3645 24814 4750
Breast 24,0063,561 12,8925,974 982597
Female Genital System 9,417732 4,9351,581 1,787382
Cervix Uteri 1,4660 811473 10973
Corpus and Uterus, NOS 4,219107 3,055598 323136
Corpus Uteri 4,153107 3,037583 307119
Uterus, NOS 660 1815 1617
Ovary 2,5066 722360 1,290128
Vagina 18162 5339 1611
Vulva 956555 26997 1520
Other Female Genital Organs 892 2514 3414
Male Genital System 17,04653 12,4552,012 1,0361,490
Prostate 16,0660 11,8231,835 9481,460
Testis 7680 522142 8222
Penis 18551 9729 35
Other Male Genital Organs 272 136 33
Urinary System 10,3312,290 5,1711,353 1,026491
Urinary Bladder 6,0962,164 2,891578 185278
Kidney and Renal Pelvis 3,91554 2,131719 823188
Ureter 23556 11741 813
Other Urinary Organs 8516 3215 1012
Eye and Orbit 2487 18922 426
Brain and Other Nervous System 1,9090 1,357263 28261
Brain 1,8040 1,301252 21230
Cranial Nerves Other Nervous System 1050 5611 731
Endocrine System 1,8291 1,175451 13468
Thyroid Gland 1,6461 1,109412 7945
Other Endocrine including Thymus 1830 6639 5523
Lymphoma 6,1300 1,7081,299 2,290833
Hodgkin Lymphoma 8310 186358 21275
Hodgkin - Nodal 8170 180354 20875
Hodgkin - Extranodal 140 64 40
Non-Hodgkin Lymphoma 5,2990 1,522941 2,078758
NHL - Nodal 3,9320 841718 1,805568
NHL - Extranodal 1,3670 681223 273190
Myeloma 1,4420 370 1,36936
Leukemia 3,2201 00 3,17544
Lymphocytic Leukemia 1,4431 00 1,42715
Acute Lymphocytic Leukemia 4170 00 4170
Chronic Lymphocytic Leukemia 9201 00 90712
Other Lymphocytic Leukemia 1060 00 1033
Myeloid and Monocytic Leukemia 1,6040 00 1,59410
Acute Myeloid Leukemia 1,0760 00 1,0697
Acute Monocytic Leukemia 540 00 540
Chronic Myeloid Leukemia 4260 00 4242
Other Myeloid/Monocytic Leukemia 480 00 471
Other Leukemia 1730 00 15419
Other Acute Leukemia 1040 00 1013
Aleukemic, Subleukemic and NOS 690 00 5316
Miscellaneous 3,2540 85 753,166

* Please note that these totals will not match those in Sections 3 and 4, as these numbers include all in situ cases, though basal and squamous skin cell cancers are still excluded.
** Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.


Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004

Summary of Sites by Race and Sex

Table of Contents